MyMD Pharmaceuticals Inc

NASDAQ:MYMD   3:59:50 PM EDT
2.22
-0.29 (-11.55%)
Products, Regulatory

MyMD Pharmaceuticals Provides Dosing Update On Phase 2 Multi-Center Clinical Trial Of MYMD-1

Published: 09/20/2022 13:31 GMT
MyMD Pharmaceuticals Inc (MYMD) - Mymd Pharmaceuticals® Provides Dosing Update on Phase 2 Multi-center Clinical Trial of Mymd-1® As a Therapy for Delaying Aging and Extending Healthy Lifespan.
Mymd Pharmaceuticals® Provides Dosing Update on Phase 2 Multi-center Clinical Trial of Mymd-1® As a Therapy for Delaying Aging and Extending Healthy Lifespan.
Mymd Pharmaceuticals Inc - Efficacy Data Anticipated in Q4 of 2022.